Physician profile
Thomas Gerald
NPI 1336587393
$2,812.31
in general payments reported to CMS, 2019-2025
18 companies · $30.53 in 2025
The $30.53 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $24.58 · 2021: $521 · 2022: $1,351 · 2023: $803 · 2024: $82.36 · 2025: $30.53.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $892 · Education: $24.02.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $891.62 |
| Education | $24.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $406.70 | 2022-2023 | |
| Profound Medical Corp. | $303.51 | 2022 | |
| Progenics Pharmaceuticals, INC. | $286.51 | 2021-2022 | |
| Blue Earth Diagnostics | $235.48 | 2021-2023 | |
| Procept Biorobotics Corporation | $209.61 | 2021 | |
| Angiodynamics, INC. | $177.00 | 2023 | Nanoknife |
| Medtronic, INC. | $162.08 | 2022 | |
| Novartis Pharmaceuticals Corporation | $160.62 | 2023 | |
| Dendreon Pharmaceuticals LLC | $159.95 | 2022 | |
| Aveo Pharmaceuticals, INC. | $131.50 | 2023 | Fotivda |
| Myovant Sciences INC. | $121.84 | 2022 | |
| Janssen Scientific Affairs, LLC | $95.68 | 2022 | |
| Photocure INC | $91.61 | 2022 | |
| Karl Storz Endoscopy-America | $85.59 | 2022 | |
| Urogen Pharma, INC. | $73.01 | 2024-2025 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $47.16 | 2023 | Lithovue |
| Sumitomo Pharma America, INC. | $39.88 | 2024 | Orgovyx |
| 180 Medical, INC. | $24.58 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Gerald listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.